BioPark
Springfield City Group has finalised an agreement to welcome biopharmaceuticals company Aegros into Springfield’s new technology hub, enabling them to develop a new blood plasma manufacturing facility. The $352 million production facility is the first of many to be built as part of the Greater Springfield precinct – named BioPark Australia – wherein multiple life-saving…